Approval · Notice of Compliance 17744 · 2016
BRIDION: Notice of Compliance 17744
Issued February 5, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17744
- Date
- February 5, 2016
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BRIDION | 02451816 | Marketed |
Medicinal ingredients
- SUGAMMADEX 100 MG per ML